Ceritinib is a kinase inhibitor compound used as an active pharmaceutical ingredient for the manufacturing of pharmaceutical products. It functions as a tyrosine kinase inhibitor and an anaplastic lymphoma kinase inhibitor.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1032900-25-6
Niclofolan
pharmaceutical raw material
2-[(4-Choloro-3-methyl-2-pyridinylmethyl)thio]-1H-benzimidazole
pharmaceutical raw material
Methyl (1S,3aS,3bS,5aR,9aR,9bS,11aS)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxylate
pharmaceutical raw material
8-Chloro-6-(2-fluorophenyl)-2-beta-L-glucopyranosyluronosyl-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-2-ium
pharmaceutical raw material
Ceritinib D7
pharmaceutical raw material
5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine
VERWOWGGCGHDQE-UHFFFAOYSA-N
CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl